Treatment of Pleural Mesothelioma: ASCO Guideline Update
Journal of Clinical Oncology · 10.03.2025 · 43 (8) · 1006-1038
DOI: 10.1200/jco-24-02425 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.03.2025. Verfasst von Hedy L Kindler und 20 weiteren Autor:innen. Beteiligte Einrichtung: University of Chicago Medicine, Chicago, IL. Hauptthemen laut MEDLINE: Pleural Neoplasms, Mesothelioma, Lung Neoplasms. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 191 Literaturangaben.
Abstract (Originalsprache)
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual . ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines . Clinical Practice Guidelines and other guidance (“Guidance”) provided by ASCO is not a comprehensive or definitive guide to treatment options. It is intended for voluntary use by clinicians and should be used in conjunction with independent professional judgment. Guidance may not be applicable to all patients, interventions, diseases or stages of diseases. Guidance is based on review and analysis of relevant literature and is not intended as a statement of the standard of care. ASCO does not endorse third-party drugs, devices, services, or therapies and assumes no responsibility for any harm arising from or related to the use of this information. See complete disclaimer in Appendix 1 and 2 (online only) for more . PURPOSE To provide evidence-based recommendations to practicing physicians and others on the management of pleural mesothelioma (PM). METHODS ASCO convened an Expert Panel of medical oncology, thoracic surgery, radiation oncology, pathology, cancer genetics, and advocacy experts to conduct an updated literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 2016 through 2024. Outcomes of interest included survival, disease-free or recurrence-free survival, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS The literature search identified 110 additional relevant studies to inform the evidence base for this guideline. RECOMMENDATIONS Evidence-based recommendations were developed for surgical cytoreduction, immunotherapy, chemotherapy, pathology, and germline testing in patients with PM. Additional information is available at www.asco.org/thoracic-cancer-guidelines .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Chicago Medicine, Chicago, IL.
- American Society of Clinical Oncology, Alexandria, VA.
- University of California San Diego Moores Cancer Center, La Jolla, CA.
- Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
- University of Wisconsin-Madison and Carbone Cancer Center, Madison, WI.
- Massachusetts General Hospital Cancer Center, Boston, MA.
ORCID-Profile: Hedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova, Quincy Chu, Jane E Churpek, Ibiayi Dagogo-Jack, Darren S Bryan, Michael W Drazer, Patrick Forde, Jennifer L Sauter, B C John Cho, Marc de Perrot, David L Graham, Ola Khorshid, Alexandra Lebensohn, Raffit Hassan
Zitieren
APA
Kindler, H. L., Ismaila, N., Bazhenova, L., Chu, Q., Churpek, J. E., Dagogo-Jack, I., Bryan, D. S., Drazer, M. W., Forde, P., Husain, A. N., Sauter, J. L., Rusch, V., Bradbury, P. A., Cho, B. C. J., de Perrot, M., Ghafoor, A., Graham, D. L., Khorshid, O., Lebensohn, A., …, & Hassan, R. (2025). Treatment of Pleural Mesothelioma: ASCO Guideline Update. Journal of Clinical Oncology, 43(8), 1006-1038. https://doi.org/10.1200/jco-24-02425
Vancouver
Kindler HL, Ismaila N, Bazhenova L, Chu Q, Churpek JE, Dagogo-Jack I, et al. Treatment of Pleural Mesothelioma: ASCO Guideline Update. Journal of Clinical Oncology. 2025;43(8):1006-1038. doi:10.1200/jco-24-02425
BibTeX
@article{Kindler2025,
author = {Kindler, Hedy L and Ismaila, Nofisat and Bazhenova, Lyudmila and Chu, Quincy and Churpek, Jane E and Dagogo-Jack, Ibiayi and Bryan, Darren S and Drazer, Michael W and Forde, Patrick and Husain, Aliya N and Sauter, Jennifer L and Rusch, Valerie and Bradbury, Penelope A and Cho, B C John and de Perrot, Marc and Ghafoor, Azam and Graham, David L and Khorshid, Ola and Lebensohn, Alexandra and White, Julie and Hassan, Raffit},
title = {Treatment of Pleural Mesothelioma: ASCO Guideline Update},
journal = {Journal of Clinical Oncology},
year = {2025},
volume = {43},
number = {8},
pages = {1006--1038},
doi = {10.1200/jco-24-02425}
}
EUVIMED